Implication of MAPK1/MAPK3 signalling pathway in t(8;9)(p22;24)/PCM1-JAK2 myelodysplastic/myeloproliferative neoplasms

被引：10

作者：

Masselli, Elena ^{[1
,2
]}

Mecucci, Cristina ^{[3
]}

Gobbi, Giuliana ^{[2
]}

Carubbi, Cecilia ^{[2
]}

Pierini, Valentina ^{[3
]}

Sammarelli, Gabriella ^{[1
]}

Bonomini, Sabrina ^{[1
]}

Prezioso, Lucia ^{[1
]}

Rossetti, Elena ^{[1
]}

Caramatti, Cecilia ^{[1
]}

Aversa, Franco ^{[1
]}

Vitale, Marco ^{[2
]}

机构：

[1] Univ Parma, Dept Clin & Expt Med, Haematol & Bone Marrow Transplantat Unit, I-43100 Parma, Italy

[2] Univ Parma, Unit Human Anat & Histol, Dept Biomed Biotechnol & Translat Sci S Bi Bi T, I-43100 Parma, Italy

[3] Univ Perugia, Lab Cytogenet & Mol Genet, Haematol Unit, I-06100 Perugia, Italy

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 162卷 / 04期

关键词：

myelodysplastic/myeloproliferative neoplasms; erythroid dysplasia; PCM1; JAK2; MAPK1/MAPK3; PCM1-JAK2; FUSION; LEUKEMIA; JAK2; T(8/9)(P22; P24); TRANSLOCATION; PCM1;

D O I：

10.1111/bjh.12392

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：563 / 566

页数：4

共 9 条

[1] The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene [J].

Bousquet, M ;

Quelen, C ;

De Mas, V ;

Duchayne, E ;

Roquefeuil, B ;

Delsol, G ;

Laurent, G ;

Dastugue, N ;

Brousset, P .

ONCOGENE, 2005, 24 (48) :7248-7252

[2] Pathology of the bone marrow and spleen in a case of myelodysplastic/myeloproliferative neoplasm associated with t(8;9)(p22;p24) involving PCM1 and JAK2 genes [J].

Dargent, Jean-Louis ;

Mathieux, Valerie ;

Vidrequin, Sebastien ;

Deghorain, Xavier ;

Vannuffel, Pascal ;

Rack, Katrina .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (01) :87-90

[3] Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case [J].

Heiss, S ;

Erdel, M ;

Gunsilius, E ;

Nachbaur, D ;

Tzankov, A .

HUMAN PATHOLOGY, 2005, 36 (10) :1148-1151

[4] Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation [J].

Laubach, Jacob P. ;

Fu, Ping ;

Jiang, Xiaohong ;

Salter, Kelly H. ;

Potti, Anil ;

Arcasoy, Murat O. .

EXPERIMENTAL HEMATOLOGY, 2009, 37 (12) :1411-1422

[5] Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2-positive chronic eosinophilic leukemia [J].

Lierman, Els ;

Selleslag, Dominik ;

Smits, Sanne ;

Billiet, Johan ;

Vandenberghe, Peter .

BLOOD, 2012, 120 (07) :1529-1531

[6] PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation [J].

Murati, A ;

Gelsi-Boyer, V ;

Adélaïde, J ;

Perot, C ;

Talmant, P ;

Giraudier, S ;

Lodé, L ;

Letessier, A ;

Delaval, B ;

Brunel, V ;

Imbert, M ;

Garand, R ;

Xerri, L ;

Birnbaum, D ;

Mozziconacci, M ;

Chaffanet, M .

LEUKEMIA, 2005, 19 (09) :1692-1696

[7] Chromosome 9p24 abnormalities: prevalence, description of novel JAK2 translocations, JAK2V617F mutation analysis and clinicopathologic correlates [J].

Patnaik, Mrinal M. ;

Knudson, Ryan A. ;

Gangat, Naseema ;

Hanson, Curtis A. ;

Pardanani, Animesh ;

Tefferi, Ayalew ;

Ketterling, Rhett P. .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (06) :518-524

[8] The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2 [J].

Reiter, A ;

Walz, C ;

Watmore, A ;

Schoch, C ;

Blau, I ;

Schlegelberger, B ;

Berger, U ;

Telford, N ;

Aruliah, S ;

Yin, JA ;

Vanstraelen, D ;

Barker, HF ;

Taylor, PC ;

O'Driscoll, A ;

Benedetti, F ;

Rudolph, C ;

Kolb, HJ ;

Hochhaus, A ;

Hehlmann, R ;

Chase, A ;

Cross, NCP .

CANCER RESEARCH, 2005, 65 (07) :2662-2667

[9] Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera [J].

Ugo, V ;

Marzac, C ;

Teyssandier, I ;

Larbret, F ;

Lécluse, Y ;

Debili, N ;

Vainchenker, W ;

Casadevall, N .

EXPERIMENTAL HEMATOLOGY, 2004, 32 (02) :179-187

← 1 →